← Leaderboards
David J Davido
University Of Kansas Lawrence
$2,765,043
Attributed
$3,895,246
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $641.1K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,895,246 · 10
By mechanism
R21$2,523,187 · 6
R01$1,253,816 · 1
P20$118,243 · 3
Top collaborators
- Lynda A. Morrison4 shared
- Andrea S Bertke2 shared
- David C Bloom2 shared
- Stuart John Macdonald2 shared
- Anthony R Fehr1 shared
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Anthony R Fehr$3,015,780
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingInfectionSimplexvirusProteinsViralVirusCellsPreventVirus ReplicationViral ProteinsVirus DiseasesMolecularPlayGene ExpressionEventInnovationViral GenesRecurrenceLatent InfectionLytic PhaseUbiquitin-Protein LigaseGenital SystemBlindnessMutant
Grant awards (19)
Determining the role of PARP14 in restricting HSV-1 replication$411,499
R21 · FY2025 · AI · contact PI
Role of ICP0 Dimerization in Herpes Simplex Virus Pathogenesis$229,624
R21 · FY2025 · AI · contact PI
Role of ICP0 Dimerization in Herpes Simplex Virus Pathogenesis$200,782
R21 · FY2024 · AI · contact PI
Identifying functional targets of HSV-1 ICP0-directed degradation$183,589
R21 · FY2021 · AI · contact PI
Identifying functional targets of HSV-1 ICP0-directed degradation$221,712
R21 · FY2020 · AI · contact PI
Identification of novel HSV-1 ICP0 E3 ligase targets by mass spectrometry in neurons$192,204
R21 · FY2019 · NS
Identification of novel HSV-1 ICP0 E3 ligase targets by mass spectrometry in neurons$245,495
R21 · FY2018 · NS
Dissecting the Contribution of Viral Genetic Variation to HSV-1 Neuropathogenesis$226,223
R21 · FY2017 · NS
Dissecting the Contribution of Viral Genetic Variation to HSV-1 Neuropathogenesis$201,337
R21 · FY2016 · NS
Viral and host responses to HSV infection$274,307
R01 · FY2010 · AI · contact PI
Improving Vaccine Safety and Efficacy to Control Primary HSV-1 Infections$209,309
R21 · FY2010 · EY
Viral and host responses to HSV infection$277,263
R01 · FY2009 · AI · contact PI
Improving Vaccine Safety and Efficacy to Control Primary HSV-1 Infections$201,413
R21 · FY2009 · EY
Viral and host responses to HSV infection$91,589
R01 · FY2009 · AI · contact PI
Viral and host responses to HSV infection$277,440
R01 · FY2008 · AI · contact PI
INBRE: KU-L: VIRAL AND HOST RESPONSES TO HSV INFECTION$43,371
P20 · FY2008 · RR · contact PI
Viral and host responses to HSV infection$333,217
R01 · FY2007 · AI · contact PI
INBRE: KU-L: VIRAL AND HOST RESPONSES TO HSV INFECTION$53,936
P20 · FY2007 · RR · contact PI
IDENTIFYING TARGETS OF E3 UBIQUITIN LIGASES:ROLE IN BRCA1-MEDIATED BREAST CANCER$20,936
P20 · FY2007 · RR · contact PI